Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120000 participants
OBSERVATIONAL
2020-12-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The use of gambling tracking data, widely acclaimed in recent years in research on online gambling given its ecological nature, could allow observing longitudinally changes in online gambling practices (both the raw gambling activity and risky behaviors) and in the use of responsible gambling (RG) tools due to the pandemic. Moreover, the combination of French and Swedish data will allow comparing two countries with very distinct politics regarding the pandemics, i.e. a lockdown in France in March - May 2020 and then in November - December 2020 compared to no lockdown in Sweden. Finally, gambling in women is on the rise and women display specific gambling behaviors, especially in early stages of the online gambling practice. The project will include the investigation of gender specificities both in the investigation of the impacts of the pandemic and in the comparison of French and Sweden gambling behaviors. Age, type of gambling activity and country (France / Sweden) will also be taken into account.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of the COVID-19 Pandemic on the Organization of Healthcare in France
NCT05013047
Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents
NCT04740658
NOsocomial Dissemination Risk of SARS-Cov2
NCT04339881
Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes
NCT04716972
Covid-19 Lockdown and Deviant Sexual Fantasies
NCT04448405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active gamblers in 2019/2020
Three panels of 40 000 gamblers active in 2019 and 2020, either in France or Sweden
No interventions assigned to this group
Newly registered gamblers in 2019 or 2020 (France and Sweden)
Six panels of 10 000 gamblers who newly registered either during the period of March-May 2019 or of March-May 2020, either in France or Sweden
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Balem M, Karlsson A, Widinghoff C, Perrot B, Challet-Bouju G, Hakansson A. Gambling and COVID-19: Swedish national gambling data from a state-owned gambling sports and casino operator. J Behav Addict. 2023 Mar 30;12(1):230-241. doi: 10.1556/2006.2022.00089. Print 2023 Mar 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC21_0010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.